WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

FDA

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

www.fda.gov

FDA RSS Channel

Filters
List of articles in category FDA
Title Published Date
FDA approves new drug to treat HIV infection 15 August 2013
FDA alerts companies to stop illegal sale of treatments for diabetes 23 July 2013
FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies 27 June 2013
FDA obtains waiver from European Commission to facilitate export for U.S. pharmaceutical manufacturers 23 June 2013
FDA budget requests $4.7 billion 11 April 2013
FDA alerts health care providers of recall of anemia drug Omontys 24 February 2013
FDA approves Pomalyst for advanced multiple myeloma 10 February 2013
FDA approves Gleevec for children with acute lymphoblastic leukemia 27 January 2013
FDA approves new seasonal influenza vaccine made using novel technology 16 January 2013
FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation 01 January 2013
FDA expands use of Xarelto to treat, reduce recurrence of blood clots 04 November 2012
FDA takes action against thousands of illegal Internet pharmacies 04 October 2012
FDA approves new treatment for advanced colorectal cancer 27 September 2012
New FDA task force will support innovation in antibacterial drug development 24 September 2012
FDA approves Lucentis to treat diabetic macular edema 12 August 2012
FDA approves first generic versions of Singulair to treat asthma, allergies 05 August 2012
More than 150 antiretroviral drugs available through PEPFAR for worldwide HIV/AIDS relief 24 July 2012
FDA approves generic versions of blood thinner Plavix 21 May 2012
FDA issues alert on potential dangers of unproven treatment for multiple sclerosis 11 May 2012
FDA approves first Boniva generics to treat or prevent osteoporosis 19 March 2012
  • Start
  • Prev
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next
  • End
Tahmeena

Business & Industry

  • Pfizer reports record full-year 2022 results
  • AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
  • Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
  • Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries

Research & Development

  • Antidepressants used for chronic pain on the rise, but are they effective?
  • Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
  • Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
  • Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
  • Power of cancer drugs may see boost by targeting newly ID'd pathway
  • A soybean protein blocks LDL cholesterol production, reducing risks of metabolic diseases
  • 500,000 missed out on blood pressure lowering drugs during pandemic

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. FDA

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.